Etoricoxib

• Description:

  Etoricoxib (MK-0663) selectively inhibited COX-2 in human whole blood assays in vitro, with an IC50 value of 1.1 ± 0.1 μM for COX-2 (LPS-induced prostaglandin E2 synthesis), compared with an IC50 value of 116 ± 8 μM for COX-1 (serum thromboxane B2 generation after clotting of the blood) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  358.84

• Molecular Formula:

  C18H15ClN2O2S

• Notes:

  Research use only, not for human use.

• Receptor:

  COX

• CAS Number:

  202409-33-4